Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 59, Issue 4, Pages 1577-1590
Publisher
Wiley
Online
2013-10-22
DOI
10.1002/hep.26898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis
- (2013) Yujin Hoshida et al. GASTROENTEROLOGY
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice
- (2012) Guangcun Huang et al. LABORATORY INVESTIGATION
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection
- (2011) S. Cmet et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C
- (2011) Edmondo Falleti et al. CYTOKINE
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor
- (2010) Tsutomu Fujii et al. BMC GASTROENTEROLOGY
- The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer
- (2009) Carmen Berasain et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
- (2009) Yury Popov et al. HEPATOLOGY
- Bile Acid-induced Epidermal Growth Factor Receptor Activation in Quiescent Rat Hepatic Stellate Cells Can Trigger Both Proliferation and Apoptosis
- (2009) Annika Sommerfeld et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocytosis and intracellular trafficking of ErbBs
- (2008) Alexander Sorkin et al. EXPERIMENTAL CELL RESEARCH
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
- (2008) Anna S. Lok et al. GASTROENTEROLOGY
- The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis
- (2008) Maria J. Perugorria et al. HEPATOLOGY
- Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis
- (2008) Kenneth K. Tanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More